MedTrace Logo

Protein Classifier for Thyroid Indeterminate Nodules

NCT04477798 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2020-07-20

No results posted yet for this study

Summary

In multi-center, prospective, double-blind cohorts, PCT-DIA/MS protein classifier supported by artificial neural networks will be validated to classify thyroid indeterminate nodules.

Conditions

  • Thyroid Nodule

Interventions

DIAGNOSTIC_TEST

PCT-DIA/MS

PCT-DIA/MS will be validated to classify FNA biopsy specimens

Sponsors & Collaborators

  • Luo Dingcun

    lead OTHER

Principal Investigators

  • Dingcun Luo · First People's Hospital of Hangzhou

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-07-01
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04477798 on ClinicalTrials.gov